An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability

An ALYREF-MYCN coactivator complex drives neuroblastoma

CRISPR/Cas9-based genome-wide screening of the deubiquitinase

Jessica Koach, PhD W. CLAY GUSTAFSON LAB AT UCSF

An ALYREF-MYCN coactivator complex drives neuroblastoma

CCNB1IP1 prevents ubiquitination‐mediated destabilization of MYCN

IGF2BP1 induces neuroblastoma via a druggable feedforward loop

Cancers, Free Full-Text

An ALYREF-MYCN coactivator complex drives neuroblastoma

CRISPR/Cas9-based genome-wide screening of the deubiquitinase

PDF) MYCN and SNRPD3 cooperate to maintain a balance of

PDF] The Nuclear Protein ALY Binds to and Modulates the Activity

An ALYREF-MYCN coactivator complex drives neuroblastoma

An ALYREF-MYCN coactivator complex drives neuroblastoma

Transcription factor activating protein 4 is synthetically lethal

SMARCE1 promotes neuroblastoma tumorigenesis through assisting